The UK economy may be facing some challenges, but for SME owners considering an exit, it's a good time to look to the US. US buyers are actively seeking acquisitions in the UK, attracted by a weak pound and improving US economic conditions—such as strong job data and a robust dollar—which combine to make UK companies particularly appealing.
At Morphose, we have deep, long-standing relationships with key investors across the Atlantic, and over the past 24 months, US buyers have accounted for a significant portion of our deals. In fact, 35% of the acquisitions we've managed were made by US firms, representing 60% of the total deal value. We handle the full advisory process, finding the right fit buyer for SME owners, negotiating and advising on terms, and smoothing out bumps and troubles that might arise during the due diligence process in order to achieve a successful exit.
US private equity firms have shown particular interest in high-growth sectors like technology, life sciences, and pharmaceuticals, which are seen as important for the acquisition of new technologies and long-term portfolio growth. However, it's not just these sectors that are in demand, other overlooked sectors offering growth potential such as facilities management that show strong recurring revenues and potential for modernisation and innovation are drawing strong interest.
So, if you’re a UK SME owner hoping to exit, it might be time to look across the Atlantic, where buyers are actively seeking UK businesses as part of a strategy to diversify and grow. This could turn what might feel like a "sour" market at home into a sweet result. If you need help in finding a potential buyer, please talk to us to see how we can assist you.
Recent Articles

Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations

Can The Ghost of CGT Past Forecast What's to Come?
Can the Ghost of CGT Past Forecast What's to Come? In our capacity as M&A advisors, we’re often asked what we think will happen to Capital Gains Tax next month (unfortunately, despite all our combined expertise we can’t fully demystify this one). However, a plotted history of CGT since its inception in 1965, not only reveals how different governments have viewed capital wealth generation, it also signals what might just come next......

Introducing Dr Tom McColm
Morphose is delighted to welcome Dr. Tom McColm as an advisor, bringing a powerful mix of academic excellence and commercial expertise in cleantech and deep-tech ventures. His proven track record in developing and scaling innovative technologies will strengthen Morphose’s advisory capabilities in critical infrastructure and defence.


